Publications
Publications
Show Results For
- All HBS Web
(4,360)
- Faculty Publications (682)
- June 2003 (Revised November 2003)
- Case
Siemens Medical Solutions: Strategic Turnaround
By: D. Quinn Mills and Julian Kurz
Describes how Siemens Medical Solutions (MED) accomplished a remarkable turnaround from a money-losing operation to one of Siemens' most profitable divisions. By late 1996, a challenging market environment in the health care industry as well as inefficiencies in the... View Details
- June 2003 (Revised May 2006)
- Case
Cipla
By: Rohit Deshpande and Laura Winig
The head of Cipla, a $325-million-dollar Indian pharmaceutical company and seller of low-cost AIDS drugs to South Africa, must decide what to do about Cipla's future. With India poised to enforce international patents in only two years, much of Cipla's product line... View Details
- March 2003 (Revised November 2005)
- Case
Bertelsmann AG
By: Bharat N. Anand, Michael G. Rukstad and Christoph Kostring
On July 28, 2002, Bertelsmann announced the firing of its CEO, Thomas Middelhoff, in a move that surprised industry observers, analysts, and many employees. Bertelsmann, a privately held company headquartered in Germany, was one of the largest global media... View Details
- March 2003 (Revised November 2003)
- Case
3i Group plc
By: G. Felda Hardymon, Josh Lerner and Ann Leamon
Brian Larcombe, CEO of 3i Group, one of the world's largest private equity firms and one of the few publicly listed ones, is deciding how best to use his firm's international network to deliver superior returns to shareholders. This case presents 3i's history and... View Details
- December 2002 (Revised February 2005)
- Case
Cap Gemini Ernst & Young (A): A Global Merger
By: Ashish Nanda
French IT consulting giant Cap Gemini is poised to purchase the consulting arm of Ernst & Young, a U.S.-based Big 5 accounting firm. In doing so, many differences need to be resolved, including negotiating with Ernst & Young entities all over the world as well as... View Details
- October 2002 (Revised February 2006)
- Case
Codex Alimentarius and Food Labeling
By: Ray A. Goldberg and Hal Hogan
Codex Alimentarius is a set of international food standards devised by the Codex Commission, a body within the United Nations jointly sponsored by the FAO and WHO. The purpose of the standards is to harmonize global trade in food products and agricultural commodities,... View Details
- September 2002 (Revised April 2006)
- Case
Istituto Clinico Humanitas (A)
By: Richard M.J. Bohmer, Gary P. Pisano and Ning Tang
Istituto Clinico Humanitas is a newly built private hospital, south of Milan, Italy, that has attained unusual profitability while treating public system patients. The hospital was built and is managed by Techosp, a subsidiary of Techint, a global engineering and... View Details
- July 2002 (Revised August 2002)
- Case
Washington Hospital Center (D): Emergency Medicine After September 11
By: Rosabeth M. Kanter and Michelle Heskett
The all-risks-ready emergency room prototype project becomes widely accepted as a need after September 11, 2001. The already operational medical informatics system, Insight, comes under heavy demand after its strong performance during crises and is noticed by various... View Details
- 2002
- Chapter
Cross Sector Collaboration: Lessons from the International Trachoma Initiative
By: Diana Barrett, James E. Austin and Sheila McCarthy
- January 2002
- Case
Price-Fixing Vignettes
By: Guhan Subramanian and Michelle Kalka
This case escribes the antitrust prosecutions in the United States and abroad of the international bulk vitamins cartel. Both the civil and criminal fines were historically high, and it was the first time the United States prosecuted foreign nationals for U.S. criminal... View Details
- November 2001
- Background Note
Global Approaches to Anti-Corruption
By: Joseph Hinsey, Guhan Subramanian and Michelle Kalka
In the 1970s, a series of unpleasant revelations about corporate conduct, culminating in the public disclosure about unsavory business practices abroad by more than 400 U.S. corporations, jarred popular perceptions concerning business ethics. Congress responded by... View Details
- September 2001 (Revised July 2009)
- Case
Buenos Aires Embotelladora S.A. (BAESA): A South American Restructuring
By: Stuart C. Gilson and Gustavo A. Herrero
In 1998, BAESA, PepsiCo's largest bottler and distributor outside North America, experienced severe financial difficulty and had to restructure its debt and business operations to avoid bankruptcy or liquidation. Based in Argentina, with operations throughout South... View Details
- August 2001 (Revised April 2003)
- Case
International Trachoma Initiative
By: Diana Barrett, James E. Austin and Sheila McCarthy
In an effort to combat trachoma, a major eye disease, the Clark Foundation entered into a partnership with Pfizer Pharmaceuticals. After a successful pilot project, a joint initiative was established (the Trachoma initiative) that has as its goal to eradicate the... View Details
- January 2001
- Case
Merck Global Health Initiatives (A)
By: James E. Austin, Diana Barrett and James Weber
The case series focuses on Merck's drug donation program and then raises new issues facing management about what to do about HIV/AIDS in Africa given the company's development of a new therapy. Describes collaboration among many parties including the Gates Foundation,... View Details
- January 2001
- Case
Merck Global Health Initiatives (B): Botswana
By: James E. Austin, Diana Barrett and James Weber
The case series focuses on Merck's drug donation program and then raises new issues facing management about what to do about HIV/AIDS in Africa given the company's development of a new therapy. Describes collaboration among many parties including the Gates Foundation,... View Details
- January 2001 (Revised May 2003)
- Case
Novartis Pharma: The Business Unit Model
By: Srikant M. Datar, Carin-Isabel Knoop and Cate Reavis
In June 2000, Novartis reorganized its pharmaceutical business to form global business units in oncology, transplantation, ophthalmology, and mature products. The remaining primary care products continued to be managed within global functions (e.g., R&D and marketing).... View Details
- 2001
- Book
Diagnosis Corruption: Fraud in Latin America's Public Hospitals
By: Rafael Di Tella and William D. Savedoff
- 2001
- Chapter
Publicly Funded Science and the Productivity of the Pharmaceutical Industry
By: Rebecca Henderson and Ian Cockburn
U.S. taxpayers funded $14.8 billion of health related research last year, four times the amount that was spent in 1970 in real terms. In this paper we evaluate the impact of these huge expenditures on the technological performance of the pharmaceutical industry. While... View Details
- December 2000 (Revised January 2001)
- Background Note
Promise of Functional Foods, The
By: Ray A. Goldberg, Carin-Isabel Knoop and Laure Mougeot Stroock
This case presents a definition of functional foods or nutraceuticals (food or food ingredients that could provide a health benefit beyond the traditional nutrients they contain), a description of some of the major obstacles to their commercialization and... View Details
- November 2000 (Revised May 2001)
- Case
State of South Carolina, The
This case presents the managerial dilemma faced by the treasurer of South Carolina in 1998. Until last year, the South Carolina state pension fund (with over $17 billion in assets) was barred by the state constitution from investing in equities. After the constitution... View Details